The antiviral treatments undergoing trial are (for the most part) very inexpensive drugs that have been known for years or even decades so they don't need addit

The antiviral treatments undergoing trial are (for the most part) very inexpensive drugs that have been known for years or even decades so they don't need additional testing once they're proven to work and can be manufactured at scale almost immediately (since the production chains already exist).